title: Options for control of foot-and-mouth disease: knowledge, capability and policy.
abstract: Foot-and-mouth disease can be controlled by zoo-sanitary measures and vaccination but this is difficult owing to the existence of multiple serotypes of the causative virus, multiple host species including wildlife and extreme contagiousness. Although intolerable to modern high-production livestock systems, the disease is not usually fatal and often not a priority for control in many developing countries, which remain reservoirs for viral dissemination. Phylogenetic analysis of the viruses circulating worldwide reveals seven principal reservoirs, each requiring a tailored regional control strategy. Considerable trade benefits accrue to countries that eradicate the disease but as well as requiring regional cooperation, achieving and maintaining this status using current tools takes a great deal of time, money and effort. Therefore, a progressive approach is needed that can provide interim benefits along the pathway to final eradication. Research is needed to understand and predict the patterns of viral persistence and emergence and to improve vaccine selection. Better diagnostic methods and especially better vaccines could significantly improve control in both the free and the affected parts of the world. In particular, vaccines with improved thermostability and a longer duration of immunity would facilitate control and make it less reliant on advanced veterinary infrastructures.
authors.affiliation: Pirbright Laboratory, Institute for Animal Health, Woking, Surrey GU24 0NF, UK. david.paton@bbsrc.ac.uk
authors.forename: David J
authors.initials: DJ
authors.lastname: Paton
authors.forename: Keith J
authors.initials: KJ
authors.lastname: Sumption
authors.forename: Bryan
authors.initials: B
authors.lastname: Charleston
mesh_terms: D000818:Animals; D000829:Animals, Domestic; D003906:Developing Countries; D004197:Disease Reservoirs / Q000662:veterinary* / Q000821:virology; D005536:Foot-and-Mouth Disease / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D029544:Foot-and-Mouth Disease Virus / Q000254:growth & development* / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D014765:Viral Vaccines
references.citation: J Virol. 2007 Sep;81(17):9357-67
references.pmid: 17567692
references.citation: Vet Rec. 2001 Dec 15;149(24):729-43
references.pmid: 11808655
references.citation: Cornell Vet. 1964 Oct;54:501-10
references.pmid: 14234053
references.citation: Immunol Today. 1996 Dec;17(12):553-8
references.pmid: 8991286
references.citation: J Comp Pathol. 2003 Jul;129(1):1-36
references.pmid: 12859905
references.citation: J Gen Virol. 2002 Oct;83(Pt 10):2455-2460
references.pmid: 12237427
references.citation: J Zoo Wildl Med. 2009 Jun;40(2):296-301
references.pmid: 19569476
references.citation: Transbound Emerg Dis. 2009 Jun;56(5):157-69
references.pmid: 19432637
references.citation: Vaccine. 2008 Mar 20;26(13):1681-7
references.pmid: 18313814
references.citation: J Virol. 1997 Apr;71(4):2606-14
references.pmid: 9060612
references.citation: Vaccine. 2008 Jun 25;26(27-28):3469-79
references.pmid: 18513836
references.citation: Virus Res. 2003 Jan;91(1):65-80
references.pmid: 12527438
references.citation: Rev Sci Tech. 2007 Dec;26(3):629-38
references.pmid: 18293611
references.citation: J Virol Methods. 2003 Feb;107(2):129-39
references.pmid: 12505626
references.citation: Vaccine. 1998 Oct;16(16):1516-22
references.pmid: 9711798
references.citation: Gene. 2005 Mar 14;347(2):273-82
references.pmid: 15777632
references.citation: Rev Sci Tech. 2006 Apr;25(1):293-311
references.pmid: 16796055
references.citation: Antiviral Res. 2008 Nov;80(2):178-84
references.pmid: 18601955
references.citation: Rev Sci Tech. 2002 Dec;21(3):437-49
references.pmid: 12523685
references.citation: J Virol Methods. 2009 Jan;155(1):10-7
references.pmid: 18848845
references.citation: Curr Top Microbiol Immunol. 2005;288:103-31
references.pmid: 15648176
references.citation: Vet J. 2009 Mar;179(3):458-61
references.pmid: 18023217
references.citation: Ann N Y Acad Sci. 2000;916:139-46
references.pmid: 11193614
references.citation: Annu Rev Immunol. 1997;15:235-70
references.pmid: 9143688
references.citation: Biologicals. 2005 Dec;33(4):227-34
references.pmid: 16289996
references.citation: Rev Sci Tech. 2002 Dec;21(3):429-36
references.pmid: 12523684
references.citation: Transbound Emerg Dis. 2008;55(1):57-72
references.pmid: 18397509
references.citation: Proc Biol Sci. 2008 Jan 7;275(1630):107-15
references.pmid: 17971324
references.citation: Vet Rec. 2006 Jul 8;159(2):53-7
references.pmid: 16829602
references.citation: J Gen Virol. 1989 Feb;70 ( Pt 2):395-403
references.pmid: 2543745
references.citation: J Immunol. 1981 Oct;127(4):1345-7
references.pmid: 6168685
references.citation: J Virol. 2007 Feb;81(3):1129-39
references.pmid: 17121791
references.citation: Rev Sci Tech. 2005 Dec;24(3):981-93
references.pmid: 16642769
references.citation: Transbound Emerg Dis. 2008;55(1):14-34
references.pmid: 18397506
references.citation: Emerg Infect Dis. 2009 Jul;15(7):1046-51
references.pmid: 19624919
references.citation: Adv Virus Res. 1999;53:111-26
references.pmid: 10582097
references.citation: Annu Rev Immunol. 1995;13:655-92
references.pmid: 7612238
references.citation: J Virol. 2008 Feb;82(3):1537-46
references.pmid: 18045932
references.citation: PLoS One. 2009;4(5):e5481
references.pmid: 19424494
references.citation: Virology. 2008 Dec 20;382(2):250-6
references.pmid: 18945462
references.citation: Transbound Emerg Dis. 2008;55(1):73-87
references.pmid: 18397510
references.citation: Rev Sci Tech. 2007 Aug;26(2):351-72
references.pmid: 17892157
references.citation: J Virol. 2006 Nov;80(22):11274-82
references.pmid: 16971422
references.citation: J Virol. 1992 Apr;66(4):1835-40
references.pmid: 1312607
references.citation: J Vet Diagn Invest. 2009 May;21(3):321-30
references.pmid: 19407083
references.citation: Vaccine. 2008 Apr 7;26(16):1982-9
references.pmid: 18342409
references.citation: Clin Microbiol Rev. 2004 Apr;17(2):465-93
references.pmid: 15084510
references.citation: J Virol. 2009 Apr;83(8):3626-36
references.pmid: 19176618
references.citation: Nat Rev Immunol. 2006 Mar;6(3):231-43
references.pmid: 16498452
references.citation: PLoS Pathog. 2008 Apr 18;4(4):e1000050
references.pmid: 18421380
references.citation: Risk Anal. 2008 Apr;28(2):303-9
references.pmid: 18419650
references.citation: PLoS One. 2008;3(10):e3434
references.pmid: 18941503
references.citation: Comp Immunol Microbiol Infect Dis. 2002 Oct;25(5-6):283-96
references.pmid: 12365805
references.citation: Vet Rec. 2008 Mar 8;162(10):315-6
references.pmid: 18326844
references.citation: J Hyg (Lond). 1975 Dec;75(3):387-97
references.pmid: 172558
references.citation: Nature. 1989 Feb 23;337(6209):709-16
references.pmid: 2537470
references.citation: Vaccine. 2007 Jul 26;25(30):5660-4
references.pmid: 17126959